Skip to main content
Skip to footer
Evelo
Biomarker Evidence of Anti-Inflammatory Effects of EDP1815 in a Phase 2 Psoriasis Clinical Trial
Home
/
Posters
/
Biomarker Evidence of Anti-Inflammatory Effects of EDP1815 in a Phase 2 Psoriasis Clinical Trial
September 7, 2022
by
